Search

everythinglearnresearchcommunity

for

Search:↓

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Chicken feather gene mutation helps understand human hair disorders.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Hair loss doesn't affect COVID-19 severity.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Some alopecia treatments might help treat COVID-19, but more research is needed.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

ADAM17 could be a potential target for treating PCOS.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.